Blood Loss and Visibility with Esmolol vs Labetalol in Endoscopic Sinus Surgery: A Randomized Clinical Trial

OBJECTIVES: Improved intraoperative visibility during functional endoscopic sinus surgery (FESS) decreases the risk of serious orbital or skull base injuries. Esmolol and labetalol have been used to reduce bleeding and achieve better visibility, but it remains unclear which drug is more effective. T...

Descripción completa

Detalles Bibliográficos
Autores principales: Lavere, Philip F, Rana, Nikunj A, Kinsky, Michael P, Funston, J Sean, Mohamed, Sharif S, Chaaban, Mohamad R
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2019
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6537490/
https://www.ncbi.nlm.nih.gov/pubmed/31205435
http://dx.doi.org/10.1177/1179550619847992

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6537490/
https://www.ncbi.nlm.nih.gov/pubmed/31205435
http://dx.doi.org/10.1177/1179550619847992

Ejemplares similares